首页 › 基金 › Catalio Capital Management, LP › COGT

Catalio Capital Management, LP 对 COGT 的持仓历史

COGENT BIOSCIENCES INC · 医疗保健

Catalio Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 COGT(COGENT BIOSCIENCES INC)167,716 股,市值约 US$5.4M,约占其申报组合的 1.00%,在其申报持仓中市值排名第 31 位。 Catalio Capital Management, LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)167.72K 股
申报持仓市值$5.37M
组合权重1.00%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Catalio Capital Management, LP 对 COGT 的持仓演变

Catalio Capital Management, LP 于 Q3 2026 首次披露 COGT 持仓:167,716 股(约 US$5.4M)。

逐季持仓明细

季度股数金额变化
Q3 2026 167.72K $5.37M 新进

关于 COGT 与 13F 数据

COGT(COGENT BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 51 只申报持有 COGT,申报仓位最大的包括:DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 COGT 的基金

查看 COGT 的全部基金持有人 →

常见问题

How long has Catalio Capital Management, LP held COGT?

Catalio Capital Management, LP has disclosed COGT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Catalio Capital Management, LP's current position in COGT?

As of Q3 2026, Catalio Capital Management, LP holds 167.72K shares of COGT (COGENT BIOSCIENCES INC), valued at $5.37M, representing 1.00% of its reported portfolio and ranking #31.

Has Catalio Capital Management, LP been buying or selling COGT?

In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in COGT.

Which other funds hold COGT?

Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.